📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Bivacor

1.1 - Company Overview

Bivacor Logo

Bivacor

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of centrifugal heart pumps, including the BiVACOR Total Artificial Heart, a long-term rotary blood pump device with magnetic levitation for patients with severe heart failure. Offers magnetic levitation to reduce mechanical wear, smart controllers that adapt pump operation to patient activity, and a portable external controller and batteries to enable mobility.

Products and services

  • BiVACOR Total Artificial Heart (TAH): A long-term device replaces the heart’s function via rotary blood pump technology and magnetic levitation for patients with severe heart failure, minimizing moving-part wear
  • Smart Controllers: A patient-responsive control unit adjusts pump operation to patient activity changes, ensuring appropriate blood flow
  • Magnetic Levitation Technology: A wear-reducing approach employs magnetic levitation to lessen mechanical contact, lowering component wear and enhancing the heart pump’s durability

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Bivacor

Farapulse Logo

Farapulse

HQ: United States Website
  • Description: Provider of catheter-based pulsed field ablation tools to treat atrial fibrillation, including the FARAPULSE PFA System that selectively ablates cardiac tissue with pulsed electric fields to minimize damage to surrounding tissues; the FARAWAVE catheter for pulmonary vein isolation in paroxysmal AF; the FARADRIVE steerable sheath for percutaneous catheter introduction; and the FARASTAR generator delivering pulsed fields.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Farapulse company profile →
LimFlow Logo

LimFlow

HQ: France Website
  • Description: Provider of minimally invasive vascular devices for chronic limb-threatening ischemia. The LimFlow System diverts blood around blocked arteries into tibial veins to restore foot perfusion, and includes the LimFlow ARC arterial catheter, V-Ceiver venous catheter, Vector valvulotome, Extension Covered Stents, and Crossing Stents. Approved in CE Mark markets; investigational use only in the U.S.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full LimFlow company profile →
Vascular Therapies Logo

Vascular Therapies

HQ: United States Website
  • Description: Provider of biopharma solutions to improve vascular surgery outcomes in patients with kidney and vascular diseases, including Sirogen, a proprietary sirolimus formulation for local perivascular drug delivery, and ACCESS 2, a Phase 3 randomized clinical trial evaluating Sirogen’s effectiveness in improving AV fistula outcomes in elderly hemodialysis patients.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Vascular Therapies company profile →
Hemosphere Logo

Hemosphere

HQ: United States Website
  • Description: Provider of proprietary graft-based vascular access solutions for dialysis, marketing the HeRO (Hemodialysis Reliable Outflow) Graft, a fully subcutaneous arteriovenous access solution for end-stage renal disease hemodialysis patients with limited access options and central venous obstruction, designed to maintain long-term access without venous anastomosis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Hemosphere company profile →
3F Therapeutics Logo

3F Therapeutics

HQ: United States Website
  • Description: Provider of cardiovascular devices and invasive and transapical aortic heart replacement technology, including enabling aortic heart valve, entrata aortic valve system, and endurance valve system, to reduce surgical cross-clamp and cardio-pulmonary bypass time, with utilization for congestive heart failure.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full 3F Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Bivacor

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Bivacor

2.2 - Growth funds investing in similar companies to Bivacor

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Bivacor

4.2 - Public trading comparable groups for Bivacor

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Bivacor

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Bivacor

What does Bivacor do?

Bivacor is a provider of centrifugal heart pumps, including the BiVACOR Total Artificial Heart, a long-term rotary blood pump device with magnetic levitation for patients with severe heart failure. Offers magnetic levitation to reduce mechanical wear, smart controllers that adapt pump operation to patient activity, and a portable external controller and batteries to enable mobility.

Who are Bivacor's competitors?

Bivacor's competitors and similar companies include Farapulse, LimFlow, Vascular Therapies, Hemosphere, and 3F Therapeutics.

Where is Bivacor headquartered?

Bivacor is headquartered in United States.

How many employees does Bivacor have?

Bivacor has 1,000 employees 🔒.

When was Bivacor founded?

Bivacor was founded in 2010 🔒.

What sector and industry vertical is Bivacor in?

Bivacor is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Bivacor

Who are the top strategic acquirers in Bivacor's sector and industry

Top strategic M&A buyers and acquirers in Bivacor's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Bivacor?

Top strategic M&A buyers groups and sectors for Bivacor include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Bivacor's sector and industry vertical

Which are the top PE firms investing in Bivacor's sector and industry vertical?

Top PE firms investing in Bivacor's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Bivacor's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Bivacor's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Bivacor's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Bivacor include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Bivacor's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Bivacor?

The key public trading comparables and valuation benchmarks for Bivacor include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Bivacor for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Bivacor with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Bivacor's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Bivacor with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Bivacor's' sector and industry vertical?

Access recent funding rounds and capital raises in Bivacor's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Bivacor